How would you measure the success of DrFirst's e-prescribing solution, EPCS Gold?

Introduction

Measuring the success of DrFirst's e-prescribing solution, EPCS Gold, requires a comprehensive approach that considers multiple stakeholders and metrics. To effectively evaluate this product's performance, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

EPCS Gold is an electronic prescribing solution specifically designed for controlled substances. It enables healthcare providers to securely and efficiently prescribe controlled substances electronically, complying with DEA regulations and improving patient safety.

Key stakeholders include:

1. Healthcare providers (physicians, nurse practitioners)
2. Pharmacies
3. Patients
4. Healthcare organizations
5. Regulatory bodies (DEA, state boards)

User flow:

1. Provider authentication: Practitioners log in using two-factor authentication.
2. Patient selection: Provider selects the patient and reviews their medication history.
3. Prescription creation: Provider enters prescription details, including drug, dosage, and quantity.
4. Verification and signing: Provider reviews and digitally signs the prescription.
5. Transmission: Prescription is securely sent to the patient's pharmacy.

EPCS Gold aligns with DrFirst's broader strategy of streamlining healthcare workflows and improving patient safety. It addresses the growing need for secure, efficient controlled substance prescribing in an increasingly digital healthcare landscape.

Compared to competitors like Surescripts and NewCrop, EPCS Gold differentiates itself through its robust security features and seamless integration with various EHR systems.

Product Lifecycle Stage: EPCS Gold is in the growth stage, with increasing adoption rates as more states mandate electronic prescribing for controlled substances.